Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases

Clinica Chimica Acta

Volumn 349, Issue 1-2, 2004, Pages 203-211

  Ljumovic, Dusanka ^a,c   Diamantis, Ioannis ^b   Alegakis, Athanasios K ^b   Kouroumalis, Elias A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c Heraklion 71110 Crete Greece ^*  (Greece)

Author keywords

Hepatitis B; Hepatitis C; Liver fibrosis; Matrix metalloproteinases; Non alcoholic steatohepatitis

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3;

ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ISOLATION; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MEASUREMENT; NONALCOHOLIC FATTY LIVER; PATIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS HEPATITIS;

BIOPSY; CHRONIC DISEASE; DNA, COMPLEMENTARY; HEPATITIS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER DISEASES; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASE 11; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; METALLOENDOPEPTIDASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 4744366744     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.06.028     Document Type: Article

References (36)

1. S.L. Friedman Liver fibrosis - from bench to bedside J. Hepatol. 38 Suppl. 1 2003 S38 S53
2. R. Esteban Management of chronic hepatitis B: an overview Semin. Liver Dis. 22 Suppl. 1 2002 1 6
3. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board. Antwerp, Belgium J. Viral Hepatitis 6 1999 35 47
4. A. Reid Nonalcoholic steatohepatitis Gastroenterology 121 2001 710 723
5. A.S. Yu, and E.B. Keefe Nonalcoholic fatty liver disease Rev. Gastroenterol. Disord. 2 2002 11 19
6. K.H.W. Boker, B. Pehle, C. Steinmetz, K. Breitenstein, M. Bahr, and R. Lichtinghagen Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis Hepato-gastroenterol. 47 2000 812 819
7. M.J.P. Arthur Matrix degradation in the liver Semin. Liver Dis. 10 1990 47 55
8. J.P. Iredale Matrix turnover in fibrogenesis Hepato-gastroenterol. 43 1996 56 71
9. S. Geisler, R. Lichtinghagen, K.H.W. Boker, and R.W. Veh Differential distribution of five members of the matrix metalloproteinase family and one inhibitor (TIMP-1) in human liver and skin Cell Tissue Res. 289 1997 173 183
10. E. Olaso, and S.L. Friedman Molecular regulation of hepatic fibrogenesis J. Hepatol. 29 1998 836 847
11. Nabeshima, T. Inoue, Y. Shimao, and T. Sameshima Matrix metalloproteainases in tumor invasion: role of cell migration (review) Pathol. Int. 52 2002 255 264
12. K.H.W. Boeker, C.I. Haberkorn, D. Michels, P. Flemming, M.P. Manns, and R. Lichtinghagen Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C Clin. Chim. Acta 316 2002 71 81
13. E. Morgunova, A. Tuuttila, U. Bergmann, M. Isupov, Y. Lindqvist, G. Schneider, and K. Tryggvason Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed Science 284 1999 1667 1670
14. T. Knittel, M. Mehde, D. Kobold, B. Saile, C. Dinter, and G. Ramadori Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β J. Hepatol. 30 1999 48 60
15. W.H. Kuo, F.P. Chou, S.C. Lu, S.C. Chu, and Y.S. Hsieh Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers Clin. Chim. Acta 294 2000 157 168
16. M.J.P. Arthur Fibrogenesis: II. Metalloproteinases and their inhibitors in liver fibrosis Am. J. Physiol.: Gastrointest. Liver Physiol. 279 2000 G245 G249
17. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histological grading and staging of chronic hepatitis J. Hepatol. 22 1995 696 699
18. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
19. J. Sambrook, E.F. Fitsch, and T. Maniatis Molecular Cloning: A laboratory Manual 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, New York
20. B. Bodey, B. Bodey JR., S. Siegel, and H. Kaiser Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas Anticancer Res. 20 2000 4585 4590
21. G.J. McKenna, Y. Chen, M. Smith, A. Meneghetti, C. Ong, R. McMaster, C.H. Scudamore, and S.W. Chung A role of matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas Am. J. Surg. 183 2002 588 594
22. G. Giannelli, C. Bergamini, F. Marinosci, E. Fransvea, M. Quaranta, L. Lupo, O. Schiraldi, and S. Antonaci Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma Int. J. Cancer 97 2002 425 431
23. N. Theret, O. Musso, B. Turlin, D. Lotrian, P. Bioulac-Sage, J.P. Campion, K. Boudjema, and B. Clement Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas Hepatology 34 2001 82 88
24. T. Terada, Y. Okada, and Y. Nakanuma Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors Hepatology 23 1996 1341 1344
25. R. Lichtinghagen, K. Breitenstein, B. Arndt, T. Kuhbacher, and K.H.W. Boker Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver Virchows Arch. 432 1998 153 158
26. R. Lichtinghagen, M.J. Bahr, M. Wehmeier, D. Michels, C.I. Haberkorn, and B. Arndt Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis Clin. Sci. 105 2003 373 382
27. R. Lichtinghagen, D. Michels, C.I. Haberkorn, B. Arndt, M. Bahr, and P. Flemming Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C J. Hepatol. 34 2001 239 247
28. S. Milani, H. Herbst, D. Schhupan, C. Grappone, G. Pellegrini, M. Pinzani, A. Casini, A. Calabro, G. Ciancio, F. Stefanini, A.K. Burroughs, and C. Surrenti Differential expression of matrix metalloproteinase-1 and -2 genes in normal and fibrotic human liver Am. J. Pathol. 144 1994 528 537
29. H. Herbst, T. Wege, S. Milani, G. Pellegrini, H.D. Orzechowski, and W.O. Bechstein Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis Am. J. Pathol. 150 1997 1647 1659
30. R. Lichtinghagen, C. Steinmetz, B. Pehle, K. Breitenstein, T. Seifert, and K.H.W. Boeker Matrix metalloproteinases in liver and serum in chronic active hepatitis C and HCV-induced cirrhosis Hepatol. Res. 14 1999 119 134
31. R. Lichtinghagen, T. Helmbrecht, B. Arndt, and K.H.W. Boker Expression pattern of matrix metalloproteinases in human liver Eur. J. Clin. Chem. Clin. Biochem. 33 1995 65 71
32. R.C. Benyon, J.P. Iredale, S. Goddard, P.J. Winwood, and M.J.P. Arthur Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver Gastroenterology 110 1996 821 831
33. N. Theret, O. Musso, A. L'Helgoualc'h, J.P. Campion, and B. Clement Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers Am. J. Pathol. 153 1998 945 954
34. T. Takahara, K. Furui, Y. Yata, B. Jin, L.P. Zhang, S. Nambu, H. Sato, M. Seiki, and A. Watanabe Dual expression of matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase in fibrotic human livers Hepatology 26 1997 1521 1529
35. T. Takahara, K. Furui, J. Funaki, Y. Nakayama, H. Itoh, C. Miyabayashi, H. Sato, M. Seiki, A. Ooshima, and A. Watanabe Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats Hepatology 21 1995 787 795
36. M. Tsutsumi, S. Urashima, Y. Matsuda, S. Takase, and A. Takada Changes in type IV collagen content in livers of patients with alcoholic liver disease Hepatology 17 1993 820 827